AstraZeneca PLC is 68.9x more valuable than Erasca, Inc. by market capitalization ($286.27 B vs $4.16 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ERAS | AZN |
|---|---|---|
| Market cap | $4.16 B | $286.27 B |
| US-listed rank | #1537 | #45 |
| Net income (latest FY) | -$124.55M | - |
| SEC filings | 326 | 1,002 |
AstraZeneca PLC is 68.9x more valuable than Erasca, Inc. by market capitalization ($286.27 B vs $4.16 B).
Full pages: Erasca, Inc. and AstraZeneca PLC, or browse the full rankings.